Segment Information (Tables)

9 Months Ended

Mar. 31, 2014

Schedule of Segment Performance Measures

Nine Months Ended March 31, 2014 and 2013:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2014
Net sales	$	112,457	$	133,746	$	124,396	$	-		$	370,599
Gross profit		34,244		30,443		20,994		-			85,681
Income (loss) before income taxes		14,961		17,328		9,008		(5,089	)		36,208

2013
Net sales	$	92,559	$	142,169	$	141,847	$	-		$	376,575
Gross profit		28,062		25,429		20,249		-			73,740
Income (loss) before income taxes		12,760		12,432		8,391		(7,276	)		26,307

Three Months Ended March 31, 2014 and 2013:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2014
Net sales	$	33,946	$	47,843	$	43,041	$	-		$	124,830
Gross profit		10,076		7,408		7,479		-			24,963
Income (loss) before income taxes		3,234		2,798		3,555		(1,683	)		7,904

2013
Net sales	$	36,299	$	61,776	$	52,796	$	-		$	150,871
Gross profit		11,052		13,382		7,093		-			31,527
Income (loss) before income taxes		5,389		8,794		3,010		(5,606	)		11,587

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details